Immune Checkpoint Inhibitor and MR-guided SBRT for Limited Progressive Metastatic Carcinoma.

NCT04376502 · clinicaltrials.gov ↗
NA
Phase
TERMINATED
Status
12
Enrollment
OTHER
Sponsor class

Stopped Poor enrollment

Conditions

Interventions

Sponsor

Baptist Health South Florida

Collaborators